181 related articles for article (PubMed ID: 9303415)
1. Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.
Doit C; Barre J; Cohen R; Bonacorsi S; Bourrillon A; Bingen EH
Antimicrob Agents Chemother; 1997 Sep; 41(9):2050-2. PubMed ID: 9303415
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime.
Friedland IR; Klugman KP
Antimicrob Agents Chemother; 1997 Sep; 41(9):1888-91. PubMed ID: 9303379
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child.
Skogen PG; Kolmannskog S; Bergh K
Clin Microbiol Infect; 2001 Jan; 7(1):39-42. PubMed ID: 11284946
[No Abstract] [Full Text] [Related]
4. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.
Klugman KP; Friedland IR; Bradley JS
Antimicrob Agents Chemother; 1995 Sep; 39(9):1988-92. PubMed ID: 8540704
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
Michaus ML; Pérez-Díaz L; de Pablos M; Lezaun MJ; López-Bayón J
Enferm Infecc Microbiol Clin; 1997 May; 15(5):276-7. PubMed ID: 9376392
[No Abstract] [Full Text] [Related]
6. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.
Goldwater PN
Int J Antimicrob Agents; 2005 Nov; 26(5):408-11. PubMed ID: 16216469
[TBL] [Abstract][Full Text] [Related]
7. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH
Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin Should Be Part of Empiric Therapy for Suspected Bacterial Meningitis.
Olarte L
J Pediatric Infect Dis Soc; 2019 May; 8(2):187-188. PubMed ID: 30496558
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
Cormican MG; Erwin ME; Jones RN
Diagn Microbiol Infect Dis; 1995; 22(1-2):119-23. PubMed ID: 7587024
[TBL] [Abstract][Full Text] [Related]
10. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins.
Viladrich PF; Cabellos C; Pallares R; Tubau F; Martínez-Lacasa J; Liñares J; Gudiol F
Antimicrob Agents Chemother; 1996 Jan; 40(1):218-20. PubMed ID: 8787909
[TBL] [Abstract][Full Text] [Related]
11. Update on the use of cefotaxime for pediatric meningitis in Portugal.
Lecour H; Miranda AM; Nogueira JA; Abreu C
Diagn Microbiol Infect Dis; 1995; 22(1-2):125-7. PubMed ID: 7587025
[TBL] [Abstract][Full Text] [Related]
12. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children.
Scholz H; Hofmann T; Noack R; Edwards DJ; Stoeckel K
Chemotherapy; 1998; 44(2):142-7. PubMed ID: 9551246
[TBL] [Abstract][Full Text] [Related]
13. [Pneumococcal meningitis: a 2-year evaluation of the cefotaxime-vancomycin combination].
Bourrillon A
Presse Med; 1999 Apr; 28(15):819-20. PubMed ID: 10325943
[No Abstract] [Full Text] [Related]
14. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
Olivier C; Cohen R; Begué P; Floret D
Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
[No Abstract] [Full Text] [Related]
15. Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sickle cell disease.
Chesney PJ; Davis Y; English BK; Wang WC
Pediatr Infect Dis J; 1995 Nov; 14(11):1013-5. PubMed ID: 8584345
[No Abstract] [Full Text] [Related]
16. Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance.
Fiore AE; Moroney JF; Farley MM; Harrison LH; Patterson JE; Jorgensen JH; Cetron M; Kolczak MS; Breiman RF; Schuchat A
Clin Infect Dis; 2000 Jan; 30(1):71-7. PubMed ID: 10619736
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis.
Fitoussi F; Doit C; Benali K; Bonacorsi S; Geslin P; Bingen E
Antimicrob Agents Chemother; 1998 Apr; 42(4):942-4. PubMed ID: 9559815
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Ahmed A; Jafri H; Lutsar I; McCoig CC; Trujillo M; Wubbel L; Shelton S; McCracken GH
Antimicrob Agents Chemother; 1999 Apr; 43(4):876-81. PubMed ID: 10103194
[TBL] [Abstract][Full Text] [Related]
19. Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae.
Catalán MJ; Fernández JM; Vazquez A; Varela de Seijas E; Suárez A; Bernaldo de Quirós JC
Clin Infect Dis; 1994 May; 18(5):766-9. PubMed ID: 8075268
[TBL] [Abstract][Full Text] [Related]
20. Empirical Treatment in Acute Bacterial Meningitis: a Plea for High Doses of Cefotaxime or Ceftriaxone.
Le Turnier P; Tattevin P; Varon E; Duval X
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0001223. PubMed ID: 36880753
[No Abstract] [Full Text] [Related]
[Next] [New Search]
